Press Release: Uxin Reports Unaudited First Quarter of Fiscal Year 2025 Financial Results

Dow Jones09-23
 lease liabilities                     12,310        11,047        1,520 
Current portion of finance 
 lease liabilities                     51,160        51,984        7,153 
Short-term borrowing from 
 third parties                         71,181       105,584       14,529 
Short-term borrowing from 
 related party                          7,000         9,500        1,307 
Current portion of long-term 
 debt (i)                             291,950             -            - 
Total current liabilities             885,148       577,620       79,482 
                              ---------------  ------------  ----------- 
 
Non-current liabilities 
Consideration payable to 
 WeBank (ii)                                -        41,947        5,772 
Finance lease liabilities           1,191,246     1,210,420      166,559 
Operating lease liabilities           154,846       153,171       21,077 
Total non-current 
 liabilities                        1,346,092     1,405,538      193,408 
                              ---------------  ------------  ----------- 
 
Total liabilities                   2,231,240     1,983,158      272,890 
                              ===============  ============  =========== 
 
Mezzanine equity 
Redeemable non-controlling 
 interests                            149,991       151,641       20,866 
Total Mezzanine equity                149,991       151,641       20,866 
                              ---------------  ------------  ----------- 
 
Shareholders' deficit 
Ordinary shares                        39,806        39,807        5,478 
Additional paid-in capital         18,928,837    18,942,103    2,606,521 
Subscription receivable from 
 shareholders                       (107,879)      (80,786)     (11,117) 
Accumulated other 
 comprehensive income                 225,090       223,874       30,806 
Accumulated deficit              (19,378,705)  (19,430,176)  (2,673,681) 
Total Uxin's shareholders' 
 deficit                            (292,851)     (305,178)     (41,993) 
                              ---------------  ------------  ----------- 
Non-controlling interests               (231)         (240)         (33) 
                              ---------------  ------------  ----------- 
Total shareholders' deficit         (293,082)     (305,418)     (42,026) 
                              ===============  ============  =========== 
 
Total liabilities, mezzanine 
 equity and shareholders' 
 deficit                            2,088,149     1,829,381      251,730 
                              ===============  ============  =========== 
 
 
 
 
* Share-based compensation charges included are as follows: 
 
                                   For the three months ended June 30, 
                                 --------------------------------------- 
                                     2023                 2024 
                                 -------------  ------------------------ 
                                      RMB             RMB          US$ 
Sales and marketing                        332              136       19 
General and administrative               9,425           11,784    1,622 
Research and development                   394              128       18 
 
 
                              Uxin Limited 
         Unaudited Reconciliations of GAAP And Non-GAAP Results 
     (In thousands except for number of shares and per share data) 
 
 
                                For the three months ended June 30, 
                           --------------------------------------------- 
                               2023                    2024 
                           -------------  ------------------------------ 
                                RMB            RMB             US$ 
Net loss, net of tax            (91,602)        (49,830)         (6,855) 
 
Add: Income tax expense              165              38               5 
Interest income                    (102)            (16)             (2) 
Interest expenses                  5,120          22,858           3,145 
Depreciation                       6,413          16,577           2,281 
EBITDA                          (80,006)        (10,373)         (1,426) 
                           -------------  --------------  -------------- 
 
Add: Share-based 
 compensation expenses            10,151          12,048           1,659 
- Sales and marketing                332             136              19 
- General and 
 administrative                    9,425          11,784           1,622 
- Research and 
 development                         394             128              18 
Other income                     (2,367)           (633)            (87) 
Other expenses                       272             800             110 
Foreign exchange 
 (losses)/gains                      425           (479)            (66) 
Dividend from long-term 
 investment                     (11,970)               -               - 
Net gain from 
 extinguishment of debt                -        (35,222)         (4,847) 
Fair value impact of the 
 issuance of senior 
 convertible preferred 
 shares                           36,869               -               - 
                           -------------  --------------  -------------- 
 
Non-GAAP adjusted EBITDA        (46,626)        (33,859)         (4,657) 
                           =============  ==============  ============== 
 
                                For the three months ended June 30, 
                           --------------------------------------------- 
                                    2023               2024 
                           -------------  ------------------------------ 
                                RMB            RMB             US$ 
Net loss attributable to 
 ordinary shareholders          (91,600)        (51,471)         (7,081) 
Add: Share-based 
 compensation expenses            10,151          12,048           1,659 
- Sales and marketing                332             136              19 
- General and 
 administrative                    9,425          11,784           1,622 
- Research and 
 development                         394             128              18 
Fair value impact of the 
 issuance of senior 
 convertible preferred 
 shares                           36,869               -               - 
Add: accretion on 
 redeemable non- 
 controlling interests                 -           1,650             227 
 
Non-GAAP adjusted net 
 loss attributable to 
 ordinary shareholders          (44,580)        (37,773)         (5,195) 
                           =============  ==============  ============== 
 
Net loss per share for 
 ordinary shareholders - 
 basic                            (0.06)               -               - 
Net loss per share for 
 ordinary shareholders - 
 diluted                          (0.06)               -               - 
Non-GAAP adjusted net 
 loss to ordinary 
 shareholders per share - 
 basic and diluted                (0.03)               -               - 
Weighted average shares 
 outstanding - basic       1,423,659,403  56,412,679,304  56,412,679,304 
Weighted average shares 
 outstanding - diluted     1,423,659,403  56,412,679,304  56,412,679,304 
 
Note: The conversion of Renminbi (RMB) into U.S. dollars $(USD)$ is based 
on the certified exchange rate of USD1.00 = RMB7.2672 as of June 28, 
2024 set forth in the H.10 statistical release of the Board of Governors 
of the Federal Reserve System. 
 

View original content:https://www.prnewswire.com/news-releases/uxin-reports-unaudited-first-quarter-of-fiscal-year-2025-financial-results-302255388.html

SOURCE Uxin Limited

 

(END) Dow Jones Newswires

September 23, 2024 04:34 ET (08:34 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment